MedTrace Logo

Anesthetic to Reduce Dysphagia After Anterior Cervical Discectomy and Fusion Surgery

NCT02376205 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2020-02-13

No results posted yet for this study

Summary

The main objective of this study is to analyze the effects of local anesthetic application into the retropharyngeal space and its ability to reduce dysphagia symptoms and/or occurrence rates in patients undergoing anterior cervical discectomy and fusion.

Conditions

Interventions

DRUG

bupivacaine hydrochloride 0.5% solution

10mL will be poured into the retropharyngeal space intraoperatively during anterior cervical discectomy and fusion procedure

DRUG

0.9% NaCl solution

10mL will be poured into the retropharyngeal space intraoperatively during anterior cervical discectomy and fusion procedure

Sponsors & Collaborators

  • Justin Parker Neurological Institute

    lead OTHER

Principal Investigators

  • Alexander Mason, MD · Boulder Neurosurgical Associates

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2019-03-11
Completion
2019-03-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02376205 on ClinicalTrials.gov